Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery

Back to Jobs

U.S. Commercial Launch Expected in the First Quarter of 2016 Webcast and Conference Call at 8:30 a.m. EST Today SAN DIEGO , Dec. 11, 2015 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for

Apply Now